Amphastar Pharmaceuticals (AMPH) PT Lowered to $22 at BMO Capital
Tweet
Share
E-mail
Get Alerts AMPH Hot Sheet
Price: $22.53 --0%
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
BMO Capital analyst Gary Nachman lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $22.00 (from $23.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aon Corp (AON) PT Lowered to $360 at BMO Capital
- TETRA Technologies Inc. (TTI) PT Lowered to $10 at Northland
- Oddity Tech Ltd (ODD) PT Raised to $16 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
